Hier eine sehr gute Zusammenfassung:
Link: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=45471966
Thanks! toucan...
I thought it was a great presentation!...
http://www.onemedplace.com/onemedforum/...ent&task=view&id=96
The CEO was talking really quickly, but he only had 15 minutes to present...He spoke clearly, and with enthusiasm, which is nice to see...I've heard many presentations where the speaker was not enthusiastic, and speaking in a monotone...He covered all the bases in an organized manner...
I just wish they had showed the slides instead of having the camera on him the whole time though...I'll try to find another place to find the slides and post screenshots of all of them...
Anyone who was expecting some earth shaking "new" news to come out during the presentation doesn't know these conferences are rarely, if not never the place to do this...Per SEC Rules, any Material Event MUST be PR'd to the world first, and not to just the attendees and online viewers of the presentation...The selloff in the last fifteen minutes were by newbies that don't know how things are really done IMO...
Hopefully, he'll have some interesting meetings on the third floor after the presentation...Who knows?...Maybe he'll be talking to parties interested in partnerships or even one of the big pharmas who's interesting in a buyout/takeover...That could make for some interesting news in the near future...
And for those folks that claim ANX only has TWO employees (LOL), look at the list from the info sheet on the company from the OneMedPlace Conference:
Management:
Brian M. Culley, M.S., M.B.A., Chief Business Officer, Senior Vice President of Business Development; Patrick Keran, J.D., General Counsel, Vice President; Michele Yelmene, Vice President of Regulatory Affairs; Mark E. Erwin, Senior Vice President, Operations; Brandi Roberts, C.P.A, M.B.A., Vice President of Finance; Jack Lief, Chairman; Mark N. K. Bagnall, C.P.A., Director; Alexander J. Denner, Ph.D., Director; Michael M. Goldberg M.D., M.B.A., Director; Mark Pykett, V.M.D., Ph.D., M.B.A., Director; Eric K. Rowinsky, M.D., Director
http://www.onemedplace.com/database/list/cid/946
Let's see how this trades tomorrow...I think the dump in the after-hours session isn't that big of a deal...
GLTA
Und ausserdem darf der CEO während seines Vortrages gar keine Kursrelevanten News bekanntgeben! Dies darf nur über eine PR erfolgen.... |
Thread abonnieren
